New Triazine Derivatives as Potent Modulators of Multidrug Resistance

Journal of Medicinal Chemistry

Volumn 35, Issue 13, 1992, Pages 2481-2496

  Dhainaut, Alain ^a   Régnier, Gilbert ^a   Atassi, Ghanem ^a   Pierré, Alain ^a   Léonce, Stéphane ^a   Kraus Berthier, Laurence ^a   Prost, Jean Francois ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 BIS(ALLYLAMINO) 6 [4 [[2,2 BIS(4 FLUOROPHENYL)ETHYL]AMINO]PIPERIDINO] 1,3,5 TRIAZINE; CALCIUM CHANNEL BLOCKING AGENT; DIPHENYLALKYLAMINE; DOXORUBICIN; GLYCOPROTEIN P; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; TRIAZENE DERIVATIVE; VERAPAMIL; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA P 388; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL LINE; CELL SURVIVAL; CRICETULUS; DRUG RESISTANCE; DRUG SYNERGISM; HAMSTERS; LEUKEMIA P388; LUNG; MEMBRANE GLYCOPROTEINS; P-GLYCOPROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZINES; TUMOR CELLS, CULTURED;

EID: 0026635292     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00091a017     Document Type: Article

References (9)

1. Endicott, J. A.; Ling, V. The biochemistry of P-glycoproteinmediated multidrug resistance. Annu. Rev. Biochem. 1989, 58, 137-171
2. Ford, J. M.; Hait, W. N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 1990, 42, 155-199.
3. Pennock, G. D.; Dalton, W. S.; Roeske, W. R.; Appleton, C. P.; Mosley, K.; Plezia, P.; Miller, T. P.; Salmon, S. E. Systemic toxic effects associated with high dose-dose verapamil infusion and chemotherapy administration. J. Natl. Cancer Inst. 1991, 83, 105-110
4. Labrid, C.; Régnier, G. L.; Laubie, M. Almitrine bismesylate: Pharmacological review and structure-activity relationships. Eur. J. Resp. Dis. 1983, 64 (suppl. 126), 185-189
5. Zamora, J. M.; Pearce, H. L.; Beck, W. T. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukaemia cells. Mol. Pharmacol. 1988, 33, 454-462
6. Pierré, A.; Dunn, T.; Kraus-Berthier, L.; Léonce, S.; Saint-Dizier, D.; Régnier, G.; Dhainaut, A.; Berlion, M.; Bizzari, J. P.; Atassi, G. In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative. In press
7. Safa, A. R.; Glover, C. J.; Sewell, J. L.; Meyers, M. B.; Biedler, J. L.; Felsted, R. L. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J. Biol. Chem. 1987, 262, 7884-7888
8. Atassi, G.; Pierré, A.; Kraus-Berthier, L.; Léonce, S.; Régnier, G.; Dhainaut, A. S9788 corrects adriamycin and vincristine resistance on human and murine tumour cells in vitro and on P388 leukemia in vivo. J. Cancer Res. Clin. Oncol. 1991, 117 (Suppl. 3), S108
9. Pierré, A.; Kraus-Berthier, L.; Atassi, G.; Cros, S.; Poupon, M. F.; Lavielle, G.; Berlion, M.; Bizzari, J. P. Preclinical antitumor activity of a new Vinca alkaloid derivative. Cancer Res. 1991, 51, 2312-2318